These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18380400)

  • 1. Characterization of solid-state forms of mebendazole.
    Kumar S; Chawla G; Sobhia ME; Bansal AK
    Pharmazie; 2008 Feb; 63(2):136-43. PubMed ID: 18380400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of solid-state forms of celecoxib.
    Chawla G; Gupta P; Thilagavathi R; Chakraborti AK; Bansal AK
    Eur J Pharm Sci; 2003 Nov; 20(3):305-17. PubMed ID: 14592696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysing the crystal purity of mebendazole raw material and its stability in a suspension formulation.
    Agatonovic-Kustrin S; Glass BD; Mangan M; Smithson J
    Int J Pharm; 2008 Sep; 361(1-2):245-50. PubMed ID: 18555626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of a new mebendazole salt: mebendazole hydrochloride.
    Brusau EV; Camí GE; Narda GE; Cuffini S; Ayala AP; Ellena J
    J Pharm Sci; 2008 Jan; 97(1):542-52. PubMed ID: 17854049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changed crystallinity of mebendazole solid dispersion: improved anthelmintic activity.
    García-Rodriguez JJ; de la Torre-Iglesias PM; Vegas-Sánchez MC; Torrado-Durán S; Bolás-Fernández F; Torrado-Santiago S
    Int J Pharm; 2011 Jan; 403(1-2):23-8. PubMed ID: 20934497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
    Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The solid-state characterization of fusidic acid.
    Gilchrist SE; Letchford K; Burt HM
    Int J Pharm; 2012 Jan; 422(1-2):245-53. PubMed ID: 22100514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid state investigation and characterization of the polymorphic and pseudopolymorphic forms of indapamide.
    Ghugare P; Dongre V; Karmuse P; Rana R; Singh D; Kumar A; Filmwala Z
    J Pharm Biomed Anal; 2010 Feb; 51(3):532-40. PubMed ID: 19796901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa.
    Liebenberg W; Dekker TG; Lötter AP; de Villiers MM
    Drug Dev Ind Pharm; 1998 May; 24(5):485-8. PubMed ID: 9876612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterization of deflazacort: thermal analysis, crystallographic and spectroscopic study.
    Cuffini SL; Ellena JF; Mascarenhas YP; Ayala AP; Sielser HW; Filho JM; Monti GA; Aiassa V; Sperandeo NR
    Steroids; 2007 Mar; 72(3):261-9. PubMed ID: 17207826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-state characterization of tacrine hydrochloride.
    Sorrenti M; Catenacci L; Bruni G; Luppi B; Bigucci F; Bettinetti G
    J Pharm Biomed Anal; 2012 Apr; 63():53-61. PubMed ID: 22326286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-state characterization of two polymorphic forms of R-albuterol sulfate.
    Palacio MA; Cuffini S; Badini R; Karlsson A; Palacios SM
    J Pharm Biomed Anal; 2007 Mar; 43(4):1531-4. PubMed ID: 17141446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms.
    Llinàs A; Burley JC; Box KJ; Glen RC; Goodman JM
    J Med Chem; 2007 Mar; 50(5):979-83. PubMed ID: 17298048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole.
    de Villiers MM; Terblanche RJ; Liebenberg W; Swanepoel E; Dekker TG; Song M
    J Pharm Biomed Anal; 2005 Jul; 38(3):435-41. PubMed ID: 15925244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low density porous carrier drug adsorption and release study by response surface methodology using different solvents.
    Sher P; Ingavle G; Ponrathnam S; Pawar AP
    Int J Pharm; 2007 Feb; 331(1):72-83. PubMed ID: 17030470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C.
    Martins FT; Neves PP; Ellena J; Camí GE; Brusau EV; Narda GE
    J Pharm Sci; 2009 Jul; 98(7):2336-44. PubMed ID: 18855910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of solvatomorphs of methotrexate using thermoanalytical and other techniques.
    Chadha R; Arora P; Kaur R; Saini A; Singla ML; Jain DS
    Acta Pharm; 2009 Sep; 59(3):245-57. PubMed ID: 19819822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical characterization of oleanolic acid nonsolvate and solvates prepared by solvent recrystallization.
    Tong HH; Wu HB; Zheng Y; Xi J; Chow AH; Chan CK
    Int J Pharm; 2008 May; 355(1-2):195-202. PubMed ID: 18207676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a discriminating dissolution test for three mebendazole polymorphs based on solubility differences.
    Swanepoel E; Liebenberg W; Devarakonda B; de Villiers MM
    Pharmazie; 2003 Feb; 58(2):117-21. PubMed ID: 12641328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.